1-4 of 4
Jonathon Vallejo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Nina Kim, Xin Wang, Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne D. Pulte, Marc R. Theoret, R. Angelo De Claro, Kelly J. Norsworthy
Journal: Blood
Blood (2024) 144 (Supplement 1): 1829.
https://doi.org/10.1182/blood-2024-208514
Published: 2024
Journal Articles

Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)

Rebecca Bystrom, Laura L. Fernandes, Joseph Wynne, Dianne Pulte, Eric Hansen, Andrew J. Belli, Anna Barcellos, Christina M. Zettler, Jonathon Vallejo, Kelly Norsworthy, Angelo De Claro, Catherine Lerro, Marc R Theoret, Ching-Kun Wang, Donna Rivera
Journal: Blood
Blood (2023) 142 (Supplement 1): 5189.
https://doi.org/10.1182/blood-2023-189060
Published: 2023
Journal Articles

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Dianne Pulte, Kelly J. Norsworthy, Laura Fernandes, Bindu Kanapuru, Catherine Lerro, Fatima Rizvi, Jonathon Vallejo, Kun Wang, Joseph Wynne, Anna Barcellos, Andrew J. Belli, Eric Hansen, Thomas Gwise, Paul Kluetz, Angelo De Claro, Ching-Kun Wang, Donna Rivera
Journal: Blood
Blood (2022) 140 (Supplement 1): 5100–5102.
https://doi.org/10.1182/blood-2022-169054
Published: 2022
Journal Articles

Response Rate, Event-Free Survival (EFS) and Overall Survival (OS) in Higher-Risk Myelodysplastic Syndromes (HR-MDS): U.S. Food and Drug Administration (FDA) Patient-Level Analyses

Nina Kim, Jonathon Vallejo, Jonathan Herz, Thomas Gwise, R. Angelo de Claro, Marc Theoret, Richard Pazdur, Kelly J. Norsworthy
Journal: Blood
Blood (2021) 138 (Supplement 1): 2604.
https://doi.org/10.1182/blood-2021-147558
Published: 2021